Women's Cancers 2017

Preventive measures are being sought for cervical and ovarian cancers.

Ovarian cancer is rare, and receives less research funding than some other cancers.

The investigational compound targets overexpressed folate receptor-alpha.

Treatment changes for the rare illness include less invasive surgery.

After eight years with no new treatments for ovarian cancer, PARP inhibitors and anti-angiogenics are benefiting patients.

Improvements to radiation therapy aim to better target gynecologic tumors while sparing healthy tissue.

Early introduction of palliative care can improve quality of life for patients with gynecologic cancers.